Mutations in both β-catenin and Hras cause HCC development at an incidence of 100%, supporting the notion that β-catenin activation is one of the hits that may be critical to the development of HCC, but that additional aberrations are necessary to initiate and promote tumorigenesis. The gene discussed is HRAS; the disease is hepatocellular carcinoma.